Nasdaq

Exact Sciences price target lowered to $67 from $82 at Stifel

Stifel lowered the firm’s price target on Exact Sciences (EXAS) to $67 from $82 and keeps a Buy rating on the shares. Below-consensus Q3 results and a reduced Q4 outlook stem from multiple issues – ...
Nasdaq

Exact Sciences price target raised to $70 from $60 at Evercore ISI

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...
Business Insider

Exact Sciences price target lowered to $65 from $72 at BofA

BofA analyst Michael Ryskin lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $72 and keeps a Buy rating on the shares. There were “few surprises” in the formal earnings release ...